and Y, as described [1] , using a LightCycler 2.0 (Roche). The glyceraldehyde phosphate dehydrogenase (GAPDH) gene was included as a non-polymorphic gene. Reference amplification curves were obtained by running in parallel QRT-PCR using as templates mixtures containing known relative amounts of donor and recipient DNAs. Negative controls (no template DNA) were invariably included, and all determinations were performed in triplicate. The intensities of all the donor-specific and recipient-specific amplimers were averaged, and % chimerism was expressed as the relative amount of donor DNA in sample DNA.
Supplemental Results

Simultaneous up-regulation of NKG2A, NKG2C and NKG2D
To determine whether or not NKG2 receptors are simultaneously up--regulated, flow cytometry data were elaborated as follows. First, we multiplied the percent positive by the mfi values of NKG2A, NKG2C and NKG2D flow cytometry determinations. The resulting products were calculated separately for CD8 and CD56 cells at T0 (before transplant), T1 (30 days after transplant) and T2 (90 days after transplant). By this means, a product slant value was assigned to each of the white, grey and black dots visible in Figs. 2 and 4. Next, the Pearson's correlation coefficients were calculated (by Microsoft Excel) among series of three product slant values (NKG2A vs NKG2C; NKG2A vs NKG2D and NKG2C vs NKG2D). The results are reported in Table S2A . From this Table, it may be appreciated that in most cases correlations are strong (>0.7), but weak or even inverse correlations may occasionally be seen. It may be concluded that up--regulation of NKG2A, NKG2C and NKG2D is in most cases simultaneous. Table S2B reports the same analysis for autotransplanted patients. The results are similar although correlations are weaker. Table  S3 shows the mfi values, Mean values and Standard Deviations of CD56 stain at the T0 (before transplant) and T90 (90 days post--transplant) time points for all the patients. It clearly appears that CD56 stain is brighter at T90 than T0, although a two--tailed Student t test (paired) shows that differences in CD56 expression is significant only in allotransplanted patients.
Increase in CD56 expression post transplant
CD56 up--regulation, in combination with the phenotypically detectable increases in NKG2 and decrease in KIR2DL expression (see text in the paper), is consistent with an 'immature' NK cell phenotype during engraftment, and with a deeper NK cell retuning in allotransplanted as compared to autotransplanted patients.
NKG2 up-regulation and clinical data
To empirically estimate the activation/inhibition balance, the sum of the slant product values Only pt. 155 (multiple myeloma) and pt. 187 (AML) clustered apart due to both high R(act/inh) values, and their longest and shortest survival times within the allotransplantation and autotransplantation groups, respectively ( Fig. S1A and S1B) . Thus, prevalence of activating receptor expression was observed in these two clinical outliers. Each dot represents a single patient, identified by number. Two outliers are indicated.
